NeoGenomics

NeoGenomics (NASDAQ:NEO) Trading Up 5.5% | 10/15/2020

… increase of 47% from the average daily volume of 915,195 shares. The stock had previously closed at $41.03. A number of analysts have weighed in on NEO shares. Guggenheim started coverage on shares of NeoGenomics in a research note on Friday, August 28th. They set a “buy” rating and a $46.00 price objective for the company. Benchmark lifted their price target on shares of NeoGenomics from $35.00 to $40.00 and …

The global market for Lung Cancer Diagnostics is projected to reach US$3.2 billion by 2025 | Benzinga | 10/14/2020

… Market, Asia-Pacific to Witness Fastest Growth Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS Agilent Technologies Inc. ( USA ) F. Hoffmann-La Roche Ltd. ( Switzerland ) Illumina, Inc. ( USA ) NeoGenomics Laboratories, Inc. ( USA ) QIAGEN N.V. ( The Netherlands ) Thermo Fisher Scientific, Inc. ( USA ) Veracyte ( USA ) 3. MARKET TRENDS & DRIVERS Increasing Prevalence and Incidence of Lung Cancer to Push the Demand for Early Diagnoses Age-Standardized Lung …

Follow NeoGenomics:    

Global Liquid Biopsy Market Analysis and Forecast, 2020-2030 & Implications of COVID-19 Pandemic on the Market - ResearchAndMarkets.com | Business Wire | 10/14/2020

… Region) 17 Company Profiles Abcodia Ltd. Bio-Rad Laboratories, Inc. Biocept, Inc. Chronix Biomedical Cynvenio Biosystems, Inc. Epic Sciences, Inc. F. Hoffmann-La Roche AG GUARDANT HEALTH, INC Illumina, Inc. Menarini Silicon Biosystems, Inc. NeoGenomics Laboratories, Inc. Personal Genome Diagnostics, Inc. Qiagen N.V. Resolution Bioscience, Inc. Thermo Fisher Scientific For more information about this report visit https://www.researchandmarkets.com/r/1h26hz Contacts ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For …

The Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochem’s Q4, Codiak Debuts | 10/14/2020

… Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Immunovant Inc (NASDAQ: IMVT ) Insmed Incorporated (NASDAQ: INSM ) Kura Oncology Inc (NASDAQ: KURA ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Madrigal MDGL ) Mirati Therapeutics Inc (NASDAQ: MRTX ) NeoGenomics , Inc. (NASDAQ: NEO ) Nevro Corp (NYSE: NVRO ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Pacific Biosciences of California Inc (NASDAQ: PACB ) PPD Inc (NASDAQ: PPD ) Rocket RCKT ) Seres Therapeutics Inc (NASDAQ: MCRB ) Spero Therapeutics Inc (NASDAQ: SPRO …

Legacy Capital Partners Inc. Trims Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO) | 10/14/2020

Legacy Capital Partners Inc. reduced its stake in NeoGenomics, Inc. (NASDAQ:NEO) by 10.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 44,600 shares of the medical research company’s stock after selling 5,000 shares during the period. Legacy Capital Partners Inc.’s holdings in NeoGenomics were worth $1,645,000 at the end of the most recent quarter …

Breast Cancer Predictive Genetic Testing Market 2020 Share, Size, Regional Trend, Future Growth, Top Players Updates, Industry Demand, Current and Future Plans by Forecast to 2025 | 10/14/2020

NeoGenomics … The report firstly introduced the Breast Cancer Predictive Genetic Testing basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return …

Investors Buy Large Volume of NeoGenomics Call Options (NASDAQ:NEO) | 10/14/2020

… a market cap of $4.53 billion, a PE ratio of -847.60 and a beta of 0.80. The stock’s fifty day moving average price is $36.96 and its 200-day moving average price is $32.59. NeoGenomics has a twelve month low of $19.40 and a twelve month high of $41.17. Get NeoGenomics alerts: NeoGenomics (NASDAQ:NEO) last issued its quarterly earnings data on Tuesday, July 28th. The medical research company reported …

NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China | 10/13/2020

… in Suzhou, China Investor Relations October 13, 2020 NeoGenomics continues to build its world-class pharma clinical research capabilities to include servicing Greater China-based clinical trials FORT MYERS, FL / ACCESSWIRE / October 13, 2020 / NeoGenomics , Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced plans to open a state-of-the-art research laboratory in China in association with the new lab PPD, Inc …

Venture Construction Group of Florida Sponsors Annual ALS Florida… | PRWeb | 10/13/2020

… of Fort Myers, 2200 Second St., Fort Myers 33901 Oct. 15: 8 a.m. to 3 p.m., City of Cape Coral, 1015 Cultural Park Blvd., Cape Coral 33990 Oct. 15: 8 a.m. to 11:30 a.m., NeoGenomics Laboratories, 12701 Commonwealth Dr., Suite 9, Fort Myers 33913 Oct. 16: 8 a.m. to 3 p.m., Cape Coral Technical College, 360 Santa Barbara Blvd. N, Cape Coral 33993 Oct. 18: 8:45 a.m. to 12:45 p.m …

NeoGenomics (NASDAQ:NEO) Rating Increased to Strong-Buy at BidaskClub | 10/13/2020

NeoGenomics (NASDAQ:NEO) Rating Increased to Strong-Buy at BidaskClub Posted by Cindy Kellogue on Oct 13th, 2020 BidaskClub upgraded shares of NeoGenomics (NASDAQ:NEO) from a buy rating to a strong-buy rating in a research note released on Friday, BidAskClub reports. Several other equities analysts have also issued reports on NEO. Zacks Investment Research lowered NeoGenomics from a strong-buy rating to a hold rating in a research …

NeoGenomics (NASDAQ:NEO) Raised to Buy at ValuEngine - WKRB News | 10/13/2020

NeoGenomics (NASDAQ:NEO) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Monday, ValuEngine reports. Other equities research analysts also recently issued research reports about the company. Guggenheim began coverage on NeoGenomics in a report on Friday, August 28th. They issued a “buy” rating and a $46.00 target price for the company. Zacks Investment Research downgraded shares of NeoGenomics from …

NeoGenomics (NASDAQ:NEO) Upgraded to Buy by ValuEngine - Ticker Report | 10/13/2020

ValuEngine upgraded shares of NeoGenomics (NASDAQ:NEO) buy rating in a report released on Monday, ValuEngine reports. NEO has been the subject of several other research reports. Guggenheim initiated coverage on shares of NeoGenomics in a report on Friday, August 28th. They issued a buy rating and a $46.00 target price for the company. BidaskClub raised NeoGenomics from a buy rating to a strong-buy rating in a report on …

NeoGenomics (NASDAQ:NEO) Sets New 52-Week High at $41.05 | 10/13/2020

… with a volume of 21757 shares trading hands. The stock had previously closed at $39.86. A number of research analysts have commented on the stock. Craig Hallum increased their price objective on shares of NeoGenomics from $36.00 to $42.00 and gave the company a “buy” rating in a research note on Wednesday, July 29th. Bank of America began coverage on shares of NeoGenomics in a research note on Thursday, June …

NeoGenomics (NASDAQ:NEO) Upgraded to Strong-Buy by BidaskClub - Dakota Financial News | 10/13/2020

BidaskClub upgraded shares of NeoGenomics (NASDAQ:NEO) from a buy rating to a strong-buy rating in a research note released on Friday morning, BidAskClub reports. A number of other research firms have also issued reports on NEO. Bank of America initiated coverage on shares of NeoGenomics in a research report on Thursday, June 25th. They set a buy rating and a $34.00 price target for the company. Zacks Investment …

PPD to Open Multipurpose Clinical Research Laboratory in Suzhou, China | Business Wire | 10/13/2020

… multiple regulatory compliance environments and fit-for-purpose situations. Analysis will be performed with molecular genomics, flow cytometry, ligand binding and LC-MS/MS to support both preclinical and clinical studies. PPD’s alliance with NeoGenomics Laboratories enhances its internal capabilities with extensive immunohistochemistry and molecular test menus. NeoGenomics operates an oncology-focused clinical trials testing lab in the same building as the PPD Laboratories’ central lab in Singapore and plans …

NeoGenomics (NASDAQ:NEO) Upgraded at BidaskClub - TheOlympiaReport | 10/12/2020

BidaskClub upgraded shares of NeoGenomics (NASDAQ:NEO) from a buy rating to a strong-buy rating in a research report report published on Friday, BidAskClub reports. Several other equities research analysts have also recently weighed in on the stock. Bank of America began coverage on shares of NeoGenomics in a research report on Thursday, June 25th. They set a buy rating and a $34.00 price objective for the company. Needham …

NeoGenomics (NASDAQ:NEO) Raised to “Strong-Buy” at BidaskClub - WKRB News | 10/12/2020

BidaskClub upgraded shares of NeoGenomics (NASDAQ:NEO) from a buy rating to a strong-buy note published on Friday morning, BidAskClub reports. Other analysts have also issued reports about the stock. Needham & Company LLC upped their price target on shares of NeoGenomics from $33.00 to $39.00 and gave the company a buy report on Wednesday, July 29th. Zacks Investment Research lowered NeoGenomics from a strong-buy report on Friday, August …

NeoGenomics (NASDAQ:NEO) Upgraded to “Strong-Buy” at BidaskClub - Ticker Report | 10/9/2020

… a “strong-buy” rating in a research note issued to investors on Friday, BidAskClub reports. Other research analysts have also recently issued research reports about the company. Craig Hallum increased their price objective on NeoGenomics from $36.00 to $42.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Morgan Stanley assumed coverage on NeoGenomics in a research report on Wednesday, September 9th. They set …

Update for Abhijeet Bendre | 10/8/2020

market research healthcare pharmaceuticals industry Global Clinical Laboratory Services Key Companies Studied In Report are: Clinical Laboratory Services, Inc., Covance Inc., Fresenius Medical Care AG & Co. KGaA, NeoGenomics Laboratories, Inc., Mayo Foundation for Medical Education and Research, SYNLAB International GmbH, Sonic Healthcare, BioReference Laboratories, UNILABS, Laboratory Corporation of America Holdings, Novartis AG, Adicon Holding Limited, and others. Get Sample Report Copy On COVID-19 Impact On Global Clinical Laboratory Services …

NeoGenomics, Inc. (NASDAQ:NEO) Receives $37.18 Consensus Target Price from Brokerages | 10/5/2020

… price objective among analysts that have covered the stock in the last year is $37.18. A number of analysts have recently weighed in on the stock. Benchmark upped their price target on shares of NeoGenomics from $35.00 to $40.00 and gave the stock a “buy” rating in a research note on Wednesday, July 29th. Bank of America initiated coverage on shares of NeoGenomics in a research note on Thursday, June …

Miami Herbert Business School’s Florida 50 Stock Index (UMIAMIFL) gained 11.26% during the third quarter of 2020 | PR Newswire | 10/5/2020

… Darden Restaurants Inc. – DRI (+32.95%) Lennar Corp – LEN (+32.55%) Watsco Inc. – WSO (+31.06%) Dycom Industries Inc. – DY (+29.18%) Royal Caribbean Cruises Ltd – RCL (+28.69%) Chatham Lodging Trust – CLDT (+24.51%) Sykes Enterprises Inc. – SYKE (+23.68%) NeoGenomics , Inc. – NEO (+19.08%) NextEra Energy Inc. – NEE (+15.57%) The University of Miami’s Florida 50 Index, which was established by Miami Herbert Business School in 2016, is based on the capitalizations of all Florida -based large …

Hematogenix Unites With 19 Organizations from the Healthcare Community to Form COVID-19 Testing Industry Consortium | PR Newswire | 10/5/2020

… Bristol Myers Squibb. Consortium members include: Alnylam Pharmaceuticals, Inc. ArcherDx, Inc. Biocartis NV Color Diaceutics, PLC DxTerity Diagnostics, Inc. Genosity, Inc. Hematogenix Laboratory Services Infinity BiologiX Interpace Pharma Solutions, Inc. Janssen Pharmaceutica, NV LabCorp NeoGenomics Laboratories, Inc. Novartis Institute for BioMedical Research Ortho-Clinical Diagnostics, Inc. Syngene International Limited Takeda Pharmaceutical Company Limited (“Takeda”) “As clinical leaders we have the responsibility of serving the critical needs of our community – 19 …

Brokerages Expect NeoGenomics, Inc. (NASDAQ:NEO) Will Post Quarterly Sales of $128.91 Million | 10/4/2020

Analysts expect that NeoGenomics, Inc. (NASDAQ:NEO) will post sales of $128.91 million for the current quarter, according to Zacks Investment Research . Three analysts have issued estimates for NeoGenomics’ earnings, with estimates ranging from $128.36 million to $130.00 million. NeoGenomics reported sales of $104.67 million in the same quarter last year, which would suggest a positive year over year growth rate of 23.2%. The firm is scheduled to issue its …

NeoGenomics, Inc. (NASDAQ:NEO) Director Sells $10,281,600.00 in Stock | 10/3/2020

… the company’s stock, valued at $6,570,383.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website . Shares of NASDAQ:NEO opened at $36.08 on Friday. NeoGenomics , Inc. has a 52-week low of $18.56 and a 52-week high of $41.03. The company has a debt-to-equity ratio of 0.25, a quick ratio of 6.44 and a current ratio of …

Steven C. Jones Sells 280,000 Shares of NeoGenomics, Inc. (NASDAQ:NEO) Stock | 10/2/2020

… shares in the company, valued at $6,570,383.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink . Shares of NEO opened at $36.84 on Friday. NeoGenomics, Inc. has a fifty-two week low of $18.52 and a fifty-two week high of $41.03. The firm’s 50 day moving average price is $37.29 and its 200 day moving average price is $31.79 …

Oncology

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… NASDAQ: ALVR) (went public Thursday) Annexon Inc (NASDAQ: ANNX) Axonics Modulation Technologies Inc (NASDAQ: AXNX) Biofrontera AG (NASDAQ: BFRA) Cardiff Oncology Inc (NASDAQ: CRDF) CareDx Inc (NASDAQ: CDNA) (reacted to second-quarter results) DarioHealth Corp … iTeos Therapeutics Inc (NASDAQ: ITOS) Meridian Bioscience, Inc. (NASDAQ: VIVO) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ …

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… NASDAQ: ALVR) (went public Thursday) Annexon Inc (NASDAQ: ANNX) Axonics Modulation Technologies Inc (NASDAQ: AXNX) Biofrontera AG (NASDAQ: BFRA) Cardiff Oncology Inc (NASDAQ: CRDF) CareDx Inc (NASDAQ: CDNA) (reacted to second-quarter results) DarioHealth Corp … iTeos Therapeutics Inc (NASDAQ: ITOS) Meridian Bioscience, Inc. (NASDAQ: VIVO) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ …

Biotech

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… filed for jobless benefits last week Popeyes parent’s revenue falls 25% despite chicken chain’s soaring same-store sales The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO © Provided by … iTeos Therapeutics Inc (NASDAQ: ITOS) Meridian Bioscience, Inc. (NASDAQ: VIVO) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ …

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… filed for jobless benefits last week Popeyes parent’s revenue falls 25% despite chicken chain’s soaring same-store sales The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO © Provided by … iTeos Therapeutics Inc (NASDAQ: ITOS) Meridian Bioscience, Inc. (NASDAQ: VIVO) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ …

Biopharma

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ: PDLI) Penumbra Inc (NYSE: PEN) Quidel Corporation (NASDAQ: QDEL) Renalytix AI PLC (NASDAQ: RNLX) Silk Road Medical Inc (NASDAQ: SILK) Shockwave Medical Inc (NASDAQ: SWAV) Sorrento Therapeutics Inc (NASDAQ: SRNE) Twist Bioscience Corp (NASDAQ: TWST) Unity Biotechnology Inc (NASDAQ: UBX) Zoetis Inc (NYSE: ZTS) Down …

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ: PDLI) Penumbra Inc (NYSE: PEN) Quidel Corporation (NASDAQ: QDEL) Renalytix AI PLC (NASDAQ: RNLX) Silk Road Medical Inc (NASDAQ: SILK) Shockwave Medical Inc (NASDAQ: SWAV) Sorrento Therapeutics Inc (NASDAQ: SRNE) Twist Bioscience Corp (NASDAQ: TWST) Unity Biotechnology Inc (NASDAQ: UBX) Zoetis Inc (NYSE: ZTS) Down …

National Cancer Institute

U.S. Solid Tumor Testing Market: Focus on Technology, Cancer Type, Biomarker Type, Application, End User, State Region, and Competitive Landscape - Analysis and Forecast, 2019-2030 | Globe Newswire | 6/4/2020

… Cancer, Liver Cancer and Other CancersRegional Segmentation• Increasing Adoption of Inorganic Growth Strategies in the Market• Increasing Research Funding from National Cancer InstituteMarket Challenges• Reimbursement Cuts in the U.S.• High Pricing Pressure• Expected Implementation of … Rad Laboratories Inc., Asuragen Inc., Cancer Genetics Inc., Invitae Corporation, NeoGenomics Laboratories, Inc., and QIAGEN N.VKey Questions Answered:• What is solid tumor testing? How have different testing technologies for solid tumor testing evolved over the …

U.S. Solid Tumor Testing Market: Focus on Technology, Cancer Type, Biomarker Type, Application, End User, State Region, and Competitive Landscape - Analysis and Forecast, 2019-2030 | Globe Newswire | 6/4/2020

… Cancer, Liver Cancer and Other CancersRegional Segmentation• Increasing Adoption of Inorganic Growth Strategies in the Market• Increasing Research Funding from National Cancer InstituteMarket Challenges• Reimbursement Cuts in the U.S.• High Pricing Pressure• Expected Implementation of … Rad Laboratories Inc., Asuragen Inc., Cancer Genetics Inc., Invitae Corporation, NeoGenomics Laboratories, Inc., and QIAGEN N.VKey Questions Answered:• What is solid tumor testing? How have different testing technologies for solid tumor testing evolved over the …

Exact Sciences

Diagnostic Methods Benefit from Rapidly Advancing Technologies | PR Newswire | 9/4/2020

Exact Sciences Corp. (NASDAQ: EXAS ), Guardant Health, Inc. (NASDAQ: GH ), GlaxoSmithKline plc (NYSE: GSK ), NeoGenomics, Inc. (NASDAQ: NEO ). The cancer diagnostics market is highly competitive, with a large number of big and small players operating in various market segments. Technological advancements in various fields such as biomarkers, imaging, biopsy, and endoscopy have benefited the market greatly over the years. As such, the growing prevalence of cancer, the rapid rise in …

GlaxoSmithKline

Diagnostic Methods Benefit from Rapidly Advancing Technologies | PR Newswire | 9/4/2020

GlaxoSmithKline plc (NYSE: GSK ), NeoGenomics, Inc. (NASDAQ: NEO ). The cancer diagnostics market is highly competitive, with a large number of big and small players operating in various market segments. Technological advancements in various fields such as biomarkers, imaging, biopsy, and endoscopy have benefited the market greatly over the years. As such, the growing prevalence of cancer, the rapid rise in aging population, increasing number of awareness initiatives by governments, and …

Illumina

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… Illumina, Inc. (NASDAQ: ILMN) Immunomedics, Inc. (NASDAQ: IMMU) Inari Medical Inc (NASDAQ: NARI) Inozyme Pharma Inc (NASDAQ: INZY) Inspire Medical Systems Inc (NYSE: INSP) (announced second-quarter results) iTeos Therapeutics Inc (NASDAQ: ITOS) Meridian Bioscience, Inc. (NASDAQ: VIVO) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ: PDLI) Penumbra Inc (NYSE: PEN) Quidel Corporation …

Bristol-Myers Squibb

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… Popeyes parent’s revenue falls 25% despite chicken chain’s soaring same-store sales The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO © Provided by Benzinga Scaling The Peaks (Biotech Stocks … iTeos Therapeutics Inc (NASDAQ: ITOS) Meridian Bioscience, Inc. (NASDAQ: VIVO) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ …

Bristol-Myers

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… Popeyes parent’s revenue falls 25% despite chicken chain’s soaring same-store sales The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO © Provided by Benzinga Scaling The Peaks (Biotech Stocks … iTeos Therapeutics Inc (NASDAQ: ITOS) Meridian Bioscience, Inc. (NASDAQ: VIVO) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ …

CareDx

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… Thursday) Annexon Inc (NASDAQ: ANNX) Axonics Modulation Technologies Inc (NASDAQ: AXNX) Biofrontera AG (NASDAQ: BFRA) Cardiff Oncology Inc (NASDAQ: CRDF) CareDx Inc (NASDAQ: CDNA) (reacted to second-quarter results) DarioHealth Corp (NASDAQ: DRIO) DexCom, Inc … iTeos Therapeutics Inc (NASDAQ: ITOS) Meridian Bioscience, Inc. (NASDAQ: VIVO) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ …

DarioHealth

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… NASDAQ: AXNX) Biofrontera AG (NASDAQ: BFRA) Cardiff Oncology Inc (NASDAQ: CRDF) CareDx Inc (NASDAQ: CDNA) (reacted to second-quarter results) DarioHealth Corp (NASDAQ: DRIO) DexCom, Inc. (NASDAQ: DXCM) Emergent Biosolutions Inc (NYSE: EBS) Fulgent Genetics … iTeos Therapeutics Inc (NASDAQ: ITOS) Meridian Bioscience, Inc. (NASDAQ: VIVO) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ …

Inspire Medical Systems

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

Inspire Medical Systems Inc (NYSE: INSP) (announced second-quarter results) iTeos Therapeutics Inc (NASDAQ: ITOS) Meridian Bioscience, Inc. (NASDAQ: VIVO) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ: PDLI) Penumbra Inc (NYSE: PEN) Quidel Corporation (NASDAQ: QDEL) Renalytix AI PLC (NASDAQ: RNLX) Silk Road Medical Inc (NASDAQ: SILK) Shockwave Medical Inc (NASDAQ: SWAV …

PDL BioPharma

The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO | MSN | 8/6/2020

… NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) ( reported positive Phase 1 data for coronavirus vaccine) OraSure Technologies, Inc. (NASDAQ: OSUR) PDL BioPharma Inc (NASDAQ: PDLI) Penumbra Inc (NYSE: PEN) Quidel Corporation (NASDAQ: QDEL) Renalytix AI PLC (NASDAQ: RNLX) Silk Road Medical Inc (NASDAQ: SILK) Shockwave Medical Inc (NASDAQ: SWAV) Sorrento Therapeutics Inc (NASDAQ: SRNE) Twist Bioscience Corp (NASDAQ: TWST) Unity Biotechnology Inc (NASDAQ: UBX) Zoetis Inc (NYSE: ZTS) Down …

Merck

Innovative Technological Advancements Improve Early Cancer Diagnoses | PR Newswire | 8/3/2020

… NeoGenomics, Inc. (NASDAQ: NEO ), Merck & Co., Inc. (NYSE: MRK ) Early diagnosis is crucial for improving chances of survival in cancer patients. Over the decades, great strides in oncology diagnostics technology have been achieved. For example, a new research published in Nature Communication Biology indicates that a way of identifying cancer biomarkers has been developed by researchers at Lund University in Sweden . The new technology allows very sensitive, quick and cost …

Seattle Genetics

Innovative Technological Advancements Improve Early Cancer Diagnoses | PR Newswire | 8/3/2020

… Seattle Genetics, Inc. (NASDAQ: SGEN ), Bristol-Myers Squibb Company (NYSE: BMY ), NeoGenomics, Inc. (NASDAQ: NEO ), Merck & Co., Inc. (NYSE: MRK ) Early diagnosis is crucial for improving chances of survival in cancer patients. Over the decades, great strides in oncology diagnostics technology have been achieved. For example, a new research published in Nature Communication Biology indicates that a way of identifying cancer biomarkers has been developed by researchers at Lund University …

Merck & Co

Innovative Technological Advancements Improve Early Cancer Diagnoses | PR Newswire | 8/3/2020

… NeoGenomics, Inc. (NASDAQ: NEO ), Merck & Co., Inc. (NYSE: MRK ) Early diagnosis is crucial for improving chances of survival in cancer patients. Over the decades, great strides in oncology diagnostics technology have been achieved. For example, a new research published in Nature Communication Biology indicates that a way of identifying cancer biomarkers has been developed by researchers at Lund University in Sweden . The new technology allows very sensitive, quick and cost …

Abbott Laboratories

The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic’s Blowout Quarter | MSN | 7/30/2020

Abbott Laboratories (NYSE: ABT) ABIOMED, Inc. (NASDAQ: ABMD) Adamis Pharmaceuticals Corp (NASDAQ: ADMP) Annexon Inc (NASDAQ: ANNX) (went public Friday) Bio-Rad Laboratories, Inc. Class B (NYSE: BIO-B ) Hologic, Inc. (NASDAQ: HOLX) Intuitive Surgical, Inc. (NASDAQ: ISRG) ITAMAR MED LTD/S ADR (NASDAQ: ITMR) Merit Medical Systems, Inc. (NASDAQ: MMSI) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) OncoSec Medical Inc (NASDAQ: ONCS) Paratek Pharmaceuticals Inc (NASDAQ: PRTK) (moved …

Bio-Rad Laboratories

The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic’s Blowout Quarter | MSN | 7/30/2020

… Bio-Rad Laboratories, Inc. Class B (NYSE: BIO-B ) Hologic, Inc. (NASDAQ: HOLX) Intuitive Surgical, Inc. (NASDAQ: ISRG) ITAMAR MED LTD/S ADR (NASDAQ: ITMR) Merit Medical Systems, Inc. (NASDAQ: MMSI) NeoGenomics, Inc. (NASDAQ: NEO) Novavax, Inc. (NASDAQ: NVAX) OncoSec Medical Inc (NASDAQ: ONCS) Paratek Pharmaceuticals Inc (NASDAQ: PRTK) (moved on rumors of a BARDA loan) Penumbra Inc (NYSE: PEN) Qiagen NV (NYSE: QGEN) Zoetis Inc (NYSE: ZTS) Down In …

ARUP Laboratories

Genetic Testing Market Analysis 2020-2024 with Profiles of Key Companies Including Genomics, Inc, Abbott Diagnostics, Agilent, Beckman Coulter, Inc, Bioarray Genetics and More | PR Newswire | 6/15/2020

… Diagnostics AccuraGen Inc Adaptive Biotechnologies Admera Health, LLC Agena Bioscience, Inc Agilent Akonni Biosystems Ancestry.com LLC Anchor Dx ArcherDx, Inc ARUP Laboratories Asuragen Baylor Miraca Genetics Laboratories Beckman Coulter , Inc Becton, Dickinson and Company BGI … Scientific MNG Labs Molecular MD NantHealth, Inc Natera Nebula Genomics NeoGenomics New Oncology Novogene Bioinformatics Technology Co., Ltd Omega Bioservices OncoDNA ORIG3N, Inc Origene Technologies Oxford Nanopore Technologies Pacific Biosciences Panagene Perkin Elmer Personal Genome …

Quest Diagnostics

Outlook on the United States Solid Tumor Testing Industry to 2030 - Analysis and Forecast | Globe Newswire | 6/8/2020

… comprise sarcomas, carcinomas, and lymphomas. The current solid tumor testing market is mainly dominated by several diagnostic majors, such as Quest Diagnostics Incorporated, Laboratory Corporation of America, Foundation Medicine, which offer a wide variety of … Rad Laboratories, Inc., Asuragen Inc., Cancer Genetics Inc., Invitae Corporation, NeoGenomics Laboratories, Inc., and QIAGEN N.V. Key trends targeted in the report: What are the emerging trends in the U.S. solid tumor testing market? How …

State of California

The Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochem’s Q4, Codiak Debuts | 10/14/2020

… NeoGenomics, Inc. (NASDAQ: NEO ) Nevro Corp (NYSE: NVRO ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Pacific Biosciences of California Inc (NASDAQ: PACB ) PPD Inc (NASDAQ: PPD ) Rocket RCKT ) Seres Therapeutics Inc (NASDAQ: MCRB ) Spero Therapeutics Inc (NASDAQ: SPRO ) Stoke Therapeutics Inc (NASDAQ: STOK ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ) Veracyte Inc (NASDAQ: VCYT ) Zai Lab …

NeoGenomics, Inc. (NASDAQ:NEO) Shares Bought by PNC Financial Services Group Inc. | 9/26/2020

PNC Financial Services Group Inc. raised its holdings in NeoGenomics, Inc. (NASDAQ:NEO) by 35.9% in the second quarter, Holdings Channel.com reports. The fund owned 35,356 shares of the medical research company’s stock after buying … after buying an additional 98,047 shares in the last quarter. California State Teachers Retirement System increased its position in shares of NeoGenomics by 7.8% in the second quarter. California State Teachers Retirement System now owns …